Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PXL770 in healthy male subjects
NCT03395470Phase 1Completed
- Sponsor
- Poxel SA
- Start
- Aug 2017
- Primary completion
- Mar 2018
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of PXL770 in type 2 diabetes mellitus (T2DM) (6 arms), sponsored by Poxel SA. Primary endpoints: Pharmacokinetics of PXL770 at Day 14 and Pharmacokinetics of Rosuvastatin at Day 14. Started Aug 2017; status: completed.
02
Drugs
PXL770
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03395470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03395470.